Show simple item record

dc.contributor.authorAhmad, Tariq
dc.date.accessioned2021-05-18T07:49:14Z
dc.date.available2021-05-18T07:49:14Z
dc.date.issued2021-01
dc.identifier.citationSazonovs A, Ahmad T, Anderson CA. Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab". Gastroenterology. 2021 Jan;160(1):470-471. doi: 10.1053/j.gastro.2020.05.102. Epub 2020 Oct 3.en_US
dc.identifier.pmid33022279
dc.identifier.doi10.1053/j.gastro.2020.05.102
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/621716
dc.language.isoenen_US
dc.publisherElsevier Scienceen_US
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0016-5085(20)35225-2en_US
dc.rights© 2021 by the AGA Instituteen_US
dc.subjectResponseen_US
dc.subjectHLA Class II Haplotypesen_US
dc.subjectDevelopment of Immunogenicityen_US
dc.subjectAdalimumaben_US
dc.subjectInfliximaben_US
dc.subjectWessex Classification Subject Headings::Gastroenterologyen_US
dc.titleUnderpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab"en_US
dc.typeLetteren_US
dc.identifier.journalGastroenterologyen_US
dc.description.fundingTariq Ahmad has received unrestricted research grants, advisory board fees, speaker honorariums, and support to attend international meetings from AbbVie, Merck, Pfizer, NAPP, Celltrion, and Hospira. The remaining authors disclose no conflicts.en_US
dc.type.versionPublisheden_US
dc.description.admin-notepublished version, accepted version, submitted versionen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record